The findings from the research – led by Professor Simon Heller of the University of Sheffield’s Department of Human Metabolism and Sheffield Teaching Hospitals NHS Foundation Trust – could offer…
Heart
Calcium scoring can be an effective tool for assessing heart disease risks in adults with no known risk factors
With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that…
Heart risks of glucose-lowering drugs being overlooked in clinical trials
Why is heart failure not more rigorously assessed in clinical trials of antidiabetes drugs? In a Personal View, published in The Lancet Diabetes & Endocrinology journal, Professor John McMurray of The University of Glasgow and colleagues review evidence that hospitalization for heart failure is one of the most common and prognostically important complications of diabetes.
Avandia (rosiglitazona) no plantea Heart Attack Riesgo, Estudio
No hay un mayor riesgo de ataque cardíaco y eventos cardiovasculares en los pacientes que toman Tipo controversial 2 Avandia (rosiglitazona), los investigadores del Instituto de Investigación Clínica Duke (DCRI) informaron después de llevar a cabo un nuevo análisis de los datos de un estudio pivotal. ..
href href=»http://www.medicalnewstoday.com/articles/261666.php»> Diabetes Noticias de Medical News Today